+91 92688 80303
+91 92688 80303
Top Alkaptonuria Doctors in India
To Book an Appointment
Call Us+91 92688 80303Filters
Doctors Available
Dr. Aniruddha Dattatraya Sonegaonkar
Associate Consultant – Orthopaedics
Orthopaedics & Joint Replacement
Experience: 17+ Years
Gender: Female
Can't find what you are looking for?
Dr. Shubham Aggarwal
Attending Consultant
Orthopaedics & Joint Replacement
Experience: 5+ Years
Gender: Male
Dr. Parul Kakkar
Attending Consultant - Internal Medicine
Internal Medicine
Experience: 9+ Years
Gender: Female
Can't find what you are looking for?
Dr. Sunita Lawange
Visiting Consultant –Pain Specialist
Orthopaedics & Joint Replacement
Gender: Female
Can't find what you are looking for?
Conditions are an all-encompassing term for all diseases, disorders and illnesses. Above doctors at Max Hospital, India are the top specialists for Alkaptonuria in India, India. Book a video consultation or in-hospital appointment to receive the best treatments with cutting edge technology. Learn more about Alkaptonuria doctors’ qualification, background, specialization and experience. Book doctor appointments online, check OPD timings at one of the best hospitals in Max Hospital, India.
Frequently Asked Questions
Alkaptonuria is a rare inherited metabolic disorder. It is characterized by the body's inability to properly break down an amino acid called phenylalanine, resulting in the accumulation of a substance called homogentisic acid.
Common symptoms of alkaptonuria include dark urine that turns black upon exposure to air, ochronosis (a condition where homogentisic acid deposits in connective tissues, leading to dark pigmentation), joint pain and stiffness, arthritis, and discolouration of the whites of the eyes.
Alkaptonuria is typically diagnosed through urine and blood tests. Urine tests can detect the presence of homogentisic acid, while blood tests may measure the levels of phenylalanine and other metabolites. Genetic testing may also confirm the presence of specific mutations associated with alkaptonuria.
Yes, alkaptonuria is considered a rare condition. It is estimated to affect approximately 1 in 250,000 to 1 in 1,000,000 individuals worldwide.
Yes, alkaptonuria is an autosomal recessive genetic disorder, which means that individuals inherit the condition when they receive two copies of the mutated gene, one from each parent carrying the gene.
Alkaptonuria is caused by mutations in the HGD gene, which provides instructions for producing an enzyme called homogentisate 1,2-dioxygenase. These mutations impair the enzyme's function, leading to the accumulation of homogentisic acid in the body.
Alkaptonuria affects the body by interfering with the breakdown of phenylalanine, resulting in the accumulation of homogentisic acid. This acid can deposit in various tissues, leading to the characteristic symptoms of the condition, including joint and connective tissue problems.
Currently, there is no cure for alkaptonuria. Treatment focuses on managing symptoms and minimizing complications through medications, lifestyle modifications, and supportive care.
There is no specific treatment for alkaptonuria, but certain therapies may help manage symptoms. These include pain management strategies, physical therapy, joint replacement surgery, and medications aimed at reducing homogentisic acid levels.
Long-term complications of alkaptonuria can include severe joint degeneration and disability, heart valve problems, kidney stones, prostate stones, and spinal disc degeneration.
Yes, alkaptonuria can affect multiple organs due to the accumulation of homogentisic acid. It primarily affects the joints, connective tissues, and urinary system, but it can also impact the heart, kidneys, eyes, and other organs.
Yes, alkaptonuria can affect the skin through a condition called ochronosis. Ochronosis is characterized by the deposition of homogentisic acid in the connective tissues, resulting in a dark pigmentation of the skin, particularly in sun-exposed areas.
Yes, alkaptonuria commonly leads to joint problems, including joint pain, stiffness, and arthritis. The deposition of homogentisic acid in the joints may cause inflammation and damage to the cartilage, leading to joint degeneration over time.
There are no dietary restrictions for individuals with alkaptonuria. However, it is generally recommended to maintain a balanced and healthy diet to support well-being.
In some cases, alkaptonuria can lead to heart problems, particularly involving the heart valves. The accumulation of homogentisic acid can cause thickening and stiffening of the valves, leading to valve dysfunction and potentially requiring surgical intervention.
Genetics play a significant role in alkaptonuria. The condition is inherited in an autosomal recessive pattern- both copies of the HGD gene must be mutated for the disorder to be present.
Yes, there is a link between alkaptonuria and arthritis. The accumulation of homogentisic acid in the joints may cause inflammation, leading to the development of arthritis.
Alkaptonuria can potentially affect vision, although it is not a common symptom. In rare cases, the deposition of homogentisic acid in the eye can cause dark pigmentation of the sclera (the whites of the eyes).
Alkaptonuria can be detected during pregnancy through genetic testing. If both parents are known carriers of the mutated gene, prenatal testing can be performed to determine if the fetus has inherited alkaptonuria.
Living with alkaptonuria can have psychological impacts due to the chronic nature of the condition, the potential for progressive joint problems, and the impact on daily life. Psychological support and counselling can be beneficial for individuals and their families.
Alkaptonuria is a metabolic disorder in itself, but there are no known direct correlations between alkaptonuria and other metabolic disorders. However, both alkaptonuria and certain metabolic disorders can involve disruptions in metabolic pathways.
Yes, alkaptonuria can lead to kidney problems, particularly the formation of kidney stones. The accumulation of homogentisic acid in the urine can contribute to the development of stones in the urinary tract.
Symptoms of alkaptonuria typically appear in adulthood, usually in the third or fourth decade of life. However, the age of symptom onset can vary among individuals.
Individuals with alkaptonuria should inform their healthcare providers about their condition before undergoing surgery or medical procedures. Precautions may be necessary to minimize the risk of complications, such as prolonged anaesthesia recovery due to the metabolism of homogentisic acid.
Yes, alkaptonuria can affect children if they inherit two copies of the mutated gene from their parents. The condition may not present symptoms immediately, but signs can appear as the child grows older.
Alkaptonuria occurs in all ethnic groups worldwide and does not have a specific association with any particular ethnicity.
There is currently no evidence to suggest that alkaptonuria directly affects fertility in men or women. However, it is important for individuals with alkaptonuria who are planning to have children to consult with healthcare professionals for appropriate guidance.
Alkaptonuria can be challenging to diagnose, and its symptoms can sometimes overlap with other conditions, such as arthritis. However, specific tests for homogentisic acid and genetic testing can help confirm the diagnosis.
Managing alkaptonuria on a daily basis can be challenging because of the progressive nature of the condition and the potential impact on joints and overall health. Regular monitoring, adherence to treatment plans, and making lifestyle adjustments may be necessary to manage symptoms effectively.
There is no direct evidence to suggest that alkaptonuria leads to premature ageing. However, the chronic nature of the condition and its potential impact on joints and overall health may contribute to a reduced quality of life.
Alkaptonuria can potentially affect cardiovascular health, particularly through heart valve problems. Regular cardiovascular monitoring may be recommended for individuals with alkaptonuria.
While alkaptonuria primarily affects physical health, the challenges associated with managing the condition and its potential impact on daily life can contribute to mental health concerns. Psychological support and counselling can be beneficial.
Alkaptonuria can significantly impact the quality of life for individuals and their families due to the chronic nature of the condition, potential joint problems, and the need for ongoing management and support. Adjustments to daily activities and emotional support are important aspects of improving quality of life.
FAQs reviewed by Dr. Arvind Bountra - Director - Paediatrics (Ped).